08 July 2017 : Clinical Research
Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma
DOI: 10.12659/MSM.902077
Med Sci Monit 2017; 23:3318-3323
HTML version available soon
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
08 July 2017 : Clinical Research
DOI: 10.12659/MSM.902077
Med Sci Monit 2017; 23:3318-3323
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.